跳至主要内容
临床试验/NCT06016504
NCT06016504终止不适用

Development and Evaluation of an Adaptive Virtual Consultation Tool for Prostate Cancer Patients

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2022年2月10日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Mayo Clinic
入组人数
18
试验地点
2
主要终点
Health outcomes for cancer recurrence using PSA

研究概览

简要总结

This clinical trial aims to design and validate an adaptive virtual consultation tool (AVCT) for men with prostate cancer (PC). An AVCT utilizes health literacy assessments in combination with learning preferences and individual disease characteristics to provide focused and guided knowledge on PC tailored to the individual patient. Using an AVCT to enhance patient education may improve patient understanding and result in higher patient satisfaction with treatment decisions amongst men with PC.

详细描述

PRIMARY OBJECTIVES:

I. To develop an adaptive virtual consultation tool for PC (AVCT):

Ia. To incorporate and integrate the inputs from a diverse group of patients (including minorities), patient advocates, nursing, physicians and education experts in the design process for the adaptive consultation tool; Ib. Employ user centered iterative design approach to develop an adaptive learning tool on mobile devices that is tailored to individuals based on symptoms, health literacy, learning style, and disease specific characteristics.

II. To assess the feasibility, acceptability and usability of AVCT:

IIa. To validate the design approach and customization rules at the completion of the participatory design process using a convenience sample of subjects through assessment of system interaction logs and qualitative feedback from users on cognition, ease-of-use, usability and customization efficacy; IIb. To utilize the feasibility study results in (2a) to refine the interface, information presentation, and adaptive customization approach.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • The participants in this study will be community dwelling, males with prostate cancer (PC) and their healthcare advocate, if applicable
  • Proficiency in English is required

排除标准

  • Mental incompetency to participate in the study and/or no treatment option due to other health reasons

结局指标

主要结局

Health outcomes for cancer recurrence using PSA

时间窗: 12-months post treatment decision

Measured by Prostate specific antigen ( PSA )

Health outcomes for sexual function using SHIM score

时间窗: Baseline

Measured using Sexual Health inventory for men (SHIM) score

Health outcomes for urinary function

时间窗: 12-months post treatment decision

Measured using International Prostate symptom score (IPSS)

Health outcomes for urinary function using IPSS

时间窗: Baseline

Measured using International Prostate symptom score (IPSS)

Health outcomes for sexual function

时间窗: 12-months post treatment decision

Measured using Sexual Health inventory for men (SHIM) score

Patient satisfaction measured by post utilization surveys

时间窗: 12-month post treatment decision

Patient's satisfaction is to be measured by post utilization surveys using general Likert scale assessment tools. Descriptive statistics will be used to summarize the data at each study time point. For all the measures collected at multiple time points, generalized linear equations (GEE) will be used to evaluate the effect of treatment and time adjusting for usage pattern.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mitchell Humphreys

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验